Boldo Restores Vascularization and Reduces Skeletal Muscle Inflammation in Symptomatic Mice with Dysferlinopathy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26209945 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Walter Vásquez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiología, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile. Hauptthemen laut MEDLINE: Muscle, Skeletal, Muscular Dystrophies, Limb-Girdle, Plant Extracts, Inflammation. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, ANID, Doctoral fellowship grants from ANID.
Abstract (Originalsprache)
Dysferlinopathies are progressive muscular dystrophies caused by DYSF mutations, leading to impaired membrane repair, chronic inflammation, lipid accumulation, and muscle degeneration. No approved therapies currently halt the progression of this disease. Here, we evaluated the effects of daily oral administration of pulverized Boldo (Peumus boldus) leaves, commonly used as a nutraceutical, to blAJ mice, a model of dysferlinopathy. Symptomatic bIAJ mice were treated for four weeks with Boldo and presented significantly improved grip strength and restored endothelial-dependent vasodilation. Muscle perfusion and capillary density in the gastrocnemius were both enhanced by treatment. Histological analyses revealed that Boldo prevented myofiber atrophy, reduced centrally nucleated fibers, and improved muscle tissue architecture. Lipid accumulation observed in blAJ muscles was absent in Boldo-treated mice. At the cellular level, Boldo normalized sarcolemma membrane permeability (dye uptake) and reduced mRNA levels of inflammasome components (NLRP3, ASC, and IL-1β), suggesting anti-inflammatory activity. These findings indicate that Boldo improves vascular and muscle integrity, supporting its potential as a complementary therapeutic strategy for dysferlinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Fisiología, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.
- Laboratorio de Fisiología Vascular, Departamento de Ciencias, Universidad del Bio-Bio, Chillán 3800708, Chile.
- Departamento de Morfología, Facultad de Medicina, Universidad Andres Bello, Santiago 8370211, Chile.
- Group of Research and Innovation in Vascular Health, GRIVAS Health, Chillán 3800708, Chile.
- Instituto de Neurociencias, Centro Interdisciplinario de Neurociencias de Valparaíso, Universidad de Valparaíso, Valparaíso 2360102, Chile.
ORCID-Profile: Walter Vásquez, Carlos Escudero, Juan C Sáez
Förderung
- Agencia Nacional de Investigación y Desarrollo
- ANID
- Doctoral fellowship grants from ANID
- Fondecyt
Zitieren
APA
Vásquez, W., Troncoso, F., Lira, A., Escudero, C., & Sáez, J. C. (2025). Boldo Restores Vascularization and Reduces Skeletal Muscle Inflammation in Symptomatic Mice with Dysferlinopathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26209945
Vancouver
Vásquez W, Troncoso F, Lira A, Escudero C, Sáez JC. Boldo Restores Vascularization and Reduces Skeletal Muscle Inflammation in Symptomatic Mice with Dysferlinopathy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26209945
BibTeX
@article{Vsquez2025,
author = {Vásquez, Walter and Troncoso, Felipe and Lira, Andrea and Escudero, Carlos and Sáez, Juan C},
title = {Boldo Restores Vascularization and Reduces Skeletal Muscle Inflammation in Symptomatic Mice with Dysferlinopathy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26209945}
}
EUVIMED